Stay Informed on Corporate Sustainability

Author: Archie Villaflores

South Korea-based Sky Labs has signed an exclusive distribution deal with Japan-based Otsuka Pharmaceutical to launch its ring-type blood pressure monitor CART BP pro in Japan. The device is prescribed in over 1,700 medical institutions in Korea.

Author: Archie Villaflores

Japan-based Takeda Pharmaceutical has signed a partnership worth over $1.7 billion (€1.44 billion) with US-based privately held Iambic to develop AI-designed small-molecule drugs. The agreement targets cancer and gastrointestinal diseases with milestone payments and royalties.

Author: Archie Villaflores

ArrayPatch has announced the first close of a €3 million seed funding round led by Lakeside Capital. The Cork company is advancing ITZ-DerMap, a novel treatment for onychomycosis using its proprietary polymer-free DerMap platform technology.

Author: Archie Villaflores

Induchem Group Ireland has acquired Cork-based MAAS to strengthen its MedTech and pharmaceutical offering. The precision engineering firm generates approximately 50 per cent of turnover from these sectors.

Author: Archie Villaflores

Bioreve Sciences, an Ireland-based food supplement manufacturer, has secured a nationwide retail distribution partnership with Uniphar Group. The IDA-supported company recently completed a two-year facility investment programme in Longford.

Author: Archie Villaflores

The pharmaceutical sector is driven by breakthroughs in research, leadership development, and integrated project delivery. In this edition, we examine how organisations are combining innovation, operational agility, and inclusive strategies to set new benchmarks across the industry. In review of a notable milestone from last year, ‘Pharmaceutical and Molecular Biotechnology Research Centre wins Research & Development Achievement Award at Pharma Industry Awards 2025’ marks a high point in ocular drug delivery and sustainability-led laboratory practices. The centre’s achievement sets the stage for 2026, emphasising the ongoing impact of R&D on industry standards and patient outcomes. Moreover, ‘BioPharmaChem Skillnet Launches Inclusive Leadership Programme for 2026’ demonstrates how targeted leadership development can shape a culture of inclusion and strategic thinking. The programme equips participants with actionable tools to influence team dynamics and foster innovation across pharmaceutical organisations. Meanwhile, ‘Partnering for Success: Tandem Delivers End-to-End Project Excellence in the Life Science Sector’ highlights how collaborative, client-focused approaches enhance project delivery across complex life science initiatives. Effective coordination and technical expertise ensure operational certainty while driving measurable outcomes. These stories underline a common thread: scientific excellence, inclusive leadership, and operational mastery are shaping the next wave of growth and impact in pharma.

Author: Jed Nykolle Harme

BioPharmaChem Skillnet launches its 2026 Inclusive Leadership Programme, blending practical workshops and personalised coaching to develop self-aware, inclusive leaders.

Author: Jed Nykolle Harme

Tandem Project Management delivers end-to-end project excellence for life science companies, combining technical expertise, regulatory compliance, and operational agility to drive innovation and measurable results.

Author: Jed Nykolle Harme

Applauded for its pioneering research in 2025, the Pharmaceutical and Molecular Biotechnology Research Centre won the Research & Development Achievement Award at the Pharma Industry Awards 2025, setting a benchmark as the sector looks toward 2026.

Author: Archie Villaflores

Vect-Horus and OliX Pharmaceuticals have launched a CNS-focused collaboration to evaluate siRNA delivery via blood-brain barrier shuttle technology. The partnership aims to accelerate RNAi-based therapeutics for hard-to-reach CNS targets.